PNC Financial Services Group Inc. reduced its stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 14.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,880 shares of the company’s stock after selling 1,529 shares during the period. PNC Financial Services Group Inc.’s holdings in HealthEquity were worth $852,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in HQY. Wasatch Advisors LP boosted its stake in HealthEquity by 6.6% during the 3rd quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock valued at $635,065,000 after purchasing an additional 483,269 shares during the period. State Street Corp raised its holdings in shares of HealthEquity by 0.8% during the third quarter. State Street Corp now owns 3,131,900 shares of the company’s stock valued at $256,346,000 after buying an additional 23,613 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of HealthEquity by 0.7% during the third quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock worth $170,197,000 after buying an additional 15,145 shares during the period. Franklin Resources Inc. grew its holdings in HealthEquity by 0.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company’s stock worth $139,369,000 after buying an additional 11,659 shares in the last quarter. Finally, Loomis Sayles & Co. L P increased its position in HealthEquity by 2.2% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock valued at $92,216,000 after acquiring an additional 24,665 shares during the period. 99.55% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the company. Barrington Research reiterated an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday. Wells Fargo & Company lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Raymond James increased their target price on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 25th. JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Finally, Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. One investment analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $112.92.
HealthEquity Price Performance
HQY stock opened at $100.72 on Tuesday. The firm has a 50-day moving average of $105.76 and a two-hundred day moving average of $95.51. The firm has a market capitalization of $8.73 billion, a PE ratio of 92.40, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59.
Insider Buying and Selling
In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.20% of the company’s stock.
About HealthEquity
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- 3 Warren Buffett Stocks to Buy Now
- Can TikTok Stock Picks Really Make You Rich?
- What is a Bond Market Holiday? How to Invest and Trade
- The “Quality” Rotation: Back to Basics Investing
- There Are Different Types of Stock To Invest In
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.